Toll Brothers Inc. (NYSE: TOL) Q4 2020 earnings call dated Dec. 08, 2020
Corporate Participants:
Douglas C. Yearley — Chairman and Chief Executive Officer
Martin P. Connor — Chief Financial Officer
Gregg Ziegler — Senior Vice President and Treasurer
Analysts:
Stephen Kim — Evercore ISI — Analyst
Truman Patterson — Wells Fargo — Analyst
Alan Ratner — Zelman & Associates — Analyst
Michael Rehaut — JP Morgan — Analyst
Anthony Pettinari — Citigroup Global Markets — Analyst
Michael Dahl — RBC Capital Market — Analyst
John Lovallo — Bank of America Merrill Lynch — Analyst
Susan Maklari — Goldman Sachs & Co. — Analyst
Kenneth Zener — Keybanc Capital Markets — Analyst
Jade Rahmani — Keefe, Bruyette & Woods — Analyst
Jack Micenko — SIG — Analyst
Matthew Bouley — Barclays — Analyst
Alex Barron — Housing Research Center — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Biogen (BIIB) stock research summary | Q3 2021
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) stock research summary | Q3 2021
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key
Listen On
